Translingual

edit
 
Commons:Category
Wikimedia Commons has more media related to:
 
Illustration of the SARS-CoV-2 viral coat

Wikispecies

Etymology

edit

SARS-CoV +‎ 2 [1]

Proper noun

edit

SARS-CoV-2

  1. (virology) Severe acute respiratory syndrome-related coronavirus 2; a virus which causes COVID-19 coronavirus disease, first discovered in 2019, in an outbreak that started in Wuhan, Hubei, China.

Synonyms

edit

(virus):

Hypernyms

edit

Hyponyms

edit

(virus): The number of variants and their names shows a dynamic growth. See e.g. Variant_of_concern

  • SARS-CoV-2 VOC
  • B.1.1.7 (UK variant, Alpha variant)
  • B.1.351 (South African variant, Beta variant)
  • B.1.1.248 (Brazilian variant, Gamma variant)
  • B.1.617.2 (Delta variant)
  • B.1.1.529 (Omikron variant)

Coordinate terms

edit

(virus):

closest known relatives to SARS-CoV-2

(viral components)

  • N501 (spike protein coding)
  • E484 (spike protein coding)
  • K417 (protein coding)
edit

(virus):

References

edit
  1. ^ BioRxviv, "Severe acute respiratory syndrome-related coronavirus – The species and its viruses, a statement of the Coronavirus Study Group", Alexander E. Gorbalenya, 11 February 2020, International Committee on Taxonomy of Viruses, Coronavirus Study Group

Further reading

edit

English

edit
 
English Wikipedia has an article on:
Wikipedia
 
Micrograph of the SARS-CoV-2 virus particles

Pronunciation

edit

Proper noun

edit

SARS-CoV-2

  1. (virology) SARS-CoV-2; SARS-related coronavirus 2
    • 2020 April, Lu, Xiaoxia, Liqiong Zhang, Hui Du, Jingjing Zhang, Yuan Y. Li, Jingyu Qu, Wenxin Zhang et al., “SARS-CoV-2 infection in children”, in New England Journal of Medicine, volume 382, number 17, →DOI:
      As of March 10, 2020, the 2019 novel coronavirus (SARS-CoV-2) has been responsible for more than 110,000 infections and 4000 deaths worldwide, but data regarding the epidemiologic characteristics and clinical features of infected children are limited.
    • 2021 June, Krause, Philip R., Thomas R. Fleming, Ira M. Longini, Richard Peto, Sylvie Briand, David L. Heymann, Valerie Beral, Matthew D. Snape, Helen Rees, Alba-Maria Ropero, Ran D. Balicer, Jakob P. Cramer, et al., “SARS-CoV-2 Variants and Vaccines”, in New England Journal of Medicine, →DOI:
      In addition to continuing to track the emergence of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there are four major priorities for the global response to variants of concern.

Synonyms

edit

Hypernyms

edit

Coordinate terms

edit
edit